Evidence map›Paper›PMID 35719359›Full record

ArticleFrontiers in cellular and infection microbiology2022

Homology Modeling,

Patrick O Sakyi, Emmanuel Broni, Richard K Amewu, Whelton A Miller, Michael D Wilson, Samuel Kojo Kwofie

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Molecular Docking and Molecular Dynamics Simulations in Related toTropical medicine and infectious disease · 2023
    Review
  6. Article
  7. InhibitingPharmaceuticals (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Patrick O SakyiDepartment of Chemistry, School of Physical and Mathematical Sciences, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
Emmanuel BroniDepartment of Biomedical Engineering, School of Engineering Sciences, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana.
Richard K AmewuDepartment of Chemistry, School of Physical and Mathematical Sciences, College of Basic and Applied Sciences, University of Ghana, Accra, Ghana.
Whelton A MillerDepartment of Medicine, Loyola University Medical Center, Maywood, IL, United States.
Michael D WilsonDepartment of Parasitology, Noguchi Memorial Institute for Medical Research (NMIMR), College of Health Sciences (CHS), University of Ghana, Accra, Ghana.
Samuel Kojo KwofieDepartment of Biomedical Engineering, School of Engineering Sciences, College of Basic & Applied Sciences, University of Ghana, Accra, Ghana.
University of Ghana · GHNoguchi Memorial Institute for Medical Research · GHUniversity of Energy and Natural Resources · GHUniversity of Pennsylvania · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic challenges pertaining to leishmaniasis due to reported chemoresistance and toxicity necessitate the need to explore novel pathways to identify plausible inhibitory molecules.

Indexed as

Antiprotozoal AgentsLeishmania donovaniLigandsMethyltransferasesMolecular Docking SimulationMolecular Dynamics SimulationSterolsAntiprotozoal AgentsLigandsMethyltransferasesSterols24-sterol methyltransferasede-novo drug designLeishmania donovanileishmaniasismolecular dockingmolecular dynamics simulation

Identifiers

PMID35719359
PMCPMC9201040
OpenAlexW4282037385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.